Trevi Therapeutics, Inc. (TRVI)
10.94
-0.11
(-1.00%)
USD |
NASDAQ |
Feb 12, 16:00
10.95
+0.01
(+0.09%)
After-Hours: 17:56
Trevi Therapeutics Market Cap : 1.403B for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 579.49M |
| Arbutus Biopharma Corp. | 774.10M |
| Bristol Myers Squibb Co. | 121.86B |
| ACADIA Pharmaceuticals, Inc. | 3.656B |
| Alnylam Pharmaceuticals, Inc. | 40.75B |
Market Cap Related Metrics
| Price to Book Value | 7.392 |
| Price | 10.94 |
| Earnings Yield | -3.39% |